Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
—·5h
Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.
Channelssemiconductors, stocksCountriesusa, europe, chinaCategoriesipo-listings
Open original source ↗Published
7/22/2026, 12:15:19 AM
Fetched
7/22/2026, 3:07:26 AM
Confidence
60 / 100
Relevance
42 / 100
Trust
—
Language
en